Unlock regulatory insights with Watson. Learn More

Declare That Morphine Sulfate Injection USP, 5 mg/ml, is Suitable for Submission in an Abbreviated New Drug Application (ANDA)

KeyWord(s) cder, ANDA, abbreviated new drug application, morphine sulfate injection, Hospira, 2012-10101, NDA 202515, 1 ml single, syringe, intravenous, PREA, therapeutic equivalence, open
Short title Declare That Morphine Sulfate Injection USP, 5 mg/ml, is Suitable for Submission in an ANDA
Docket Item Code P
Center CDER
VIEW ALL (3)Primary Documents